A unique ligand‐steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure‐based virtual screening-Reference-Cited by-同舟云学术

A unique ligand‐steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure‐based virtual screening

Published:2021-01-16 Issue:4 Volume:97 Page:944-961
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Jin Hongwei¹,Xia Jie²,Liu Zhenming¹,Wang Xiang Simon³,Zhang Liangren¹

Affiliation:

1. State Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing China

2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines Department of New Drug Research and Development Institute of Materia Medica Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Molecular Modeling and Drug Discovery Core for District of Columbia Center for AIDS Research (DC CFAR) Laboratory of Cheminformatics and Drug Design Department of Pharmaceutical Sciences College of Pharmacy Howard University Washington DC USA

Funder

District of Columbia Developmental Center for AIDS Research

National Natural Science Foundation of China

China Scholarship Council

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13820

Reference56 articles.

1. The ChEMBL bioactivity database: an update

2. CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach

3. Epilepsy, Seizures, and Inflammation: Role of the C-C Motif Ligand 2 Chemokine

4. Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity

5. Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 – 2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5;2023-11-17

2. Small molecule metabolites: discovery of biomarkers and therapeutic targets;Signal Transduction and Targeted Therapy;2023-03-20